The combined luminol/isoluminol chemiluminescence method for differentiating between extracellular and intracellular oxidant production by neutrophils

Authors: Jancinová, Viera1; Drábiková, Katarína1; Nosál, Radomír1; Racková, Lucia1; Májeková, Magdaléna1; Holománová, Dagmar2

Source: Redox Report, Volume 11, Number 3, June 2006 , pp. 110-116(7)

Publisher: Maney Publishing

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

To address the question why isoluminol, but not luminol, failed to detect oxidants produced intracellularly, differences between these luminophores were investigated with respect to physicochemical parameters and the character of chemiluminescence signal. Our results showed the isoluminol molecule to be more polar, more hydrophilic and possessing lower ability to form intramolecular bonds than the luminol molecule. Therefore, isoluminol: (i) only slightly pervaded biological membranes; (ii) depended essentially on extracellular peroxidase; (iii) did not produce chemiluminescence in the presence of extracellular scavengers; and (iv) it could be considered a specific detector of extracellular radicals. On the other hand, the physicochemical parameters of luminol and partial resistance of its chemiluminescence to the effect of extracellular inhibitors proved the lipo/hydrophilic character of this luminophore and thus its ability to interact with radicals both outside and inside of cells. The luminol chemiluminescence measured in the presence of extracellular scavengers and the isoluminol chemiluminescence were used with the intention to differentiate the effects of two antihistamine drugs on intra- and extracellular radical formation. In activated human neutrophils, brompheniramine inhibited the extracellular and potentiated the intracellular part of chemiluminescence signal, whereas a reducing effect of loratadine was observed in both compartments.

Keywords: POLYMORPHONUCLEAR LEUKOCYTES; LUMINOL; EXTRACELLULAR AND INTRACELLULAR CHEMILUMINESCENCE; ANTIOXIDATIVE DRUGS; ISOLUMINOL

Document Type: Research Article

DOI: http://dx.doi.org/10.1179/135100006X116592

Affiliations: 1: Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic 2: National Transfusion Service, Bratislava, Slovak Republic

Publication date: 2006-06-01

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page